Quantification of Long-term Survival Benefit in a Comparative Oncology Clinical Study

This study compares conventional hazard ratios and an alternative, clinically interpretable approach to quantify the long-term survival benefit in patients receiving chemotherapy with immunotherapy.

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:JAMA Oncol
Asıl Yazarlar: Horiguchi, Miki, Tian, Lu, Uno, Hajime, Cheng, SuChun, Kim, Dae Hyun, Schrag, Deb, Wei, Lee-Jen
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Medical Association 2018
Konular:
Research Letter
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6145678/
https://ncbi.nlm.nih.gov/pubmed/29801103
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2018.0518
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller